Cancer research is one of the most innovative fields of medical science, but sometimes clues for defeating this long-standing disease that does not need to be found in future technologies, but can be found in old solutions and techniques that were left forgotten. One of the latest developments in the fight against cancer were found in the medical cabinets of almost everyone in the world – in a pill of ordinary aspirin.
Aspirin (acetylsalicylic acid) is one of the most popular population that can help you ease the symptoms of pain, inflammation, fever, can reduce the risk of strokes, blood clots, and can even decrease a risk of death after heart attack. The latest research has confirmed that aspirin can also be used as a tool management of cancers. More precisely, it was found that aspirin may help you prevent spreading of cancer cells across your body after the development of a tumor.
The process of spreading of cancerous cells from one location to another is done with the help of the cells called platelets, which can gather cancerous cells and safely carry them through the bloodstream to a new location without being detected by the body’s immune system. After cancerous cells have arrived at a new location, the same platelets also provide them with oxygen and nutrients that enable cancerous cells to start multiplying. Each year, 1.6 million new patients are diagnosed with cancer only in the United States, and more than half of a million die as a result of this deadly disease.
Researchers at Brigham and Women’s Hospital in Boston have performed the study on lab mixes in which they confirmed that aspirin disturbed the normal process of cancer proliferation across the tissue. In the presence of aspirin, palettes became unable to assists cancerous cells when they became dislodged from the tumor, which enabled mice immune system to be much more effective in containing the threat of cancer spreading.
However, even though the initial result looked promising, the researchers are well aware that treatment with aspirin will not help anyone who was diagnosed with cancer. More worryingly, they fear that regular use of aspirins by cancer patients can increase the risk of developing health complications such as bleeding. Andrew Chan, an epidemiologist at Harvard Medical School has described results of this study:
“It’s challenging to develop a single molecular test that will tell you if someone will respond [to aspirin] or not because it’s become clear that there is no single pathway by which aspirin works.”
One of the possible solutions for fixing the low compatibility of aspirin treatment with a wide array of cancer types is to gain a closer insight into how the presence of aspirin affects the activation of genes in palettes. Scientists believe that their next target must be the development of genetic tests that will ascertain whether or not aspirin treatment would be viable for the selected patient. Other studies are also planning to revisit of the interesting side effects of aspirin treatment.
You may be interested
Aleve Direct Therapy from Bayer can relieve your back painTelehealther - Jun 26, 2017
Bayer, a German multinational chemical, pharmaceutical and life sciences company, has announced the release of their new consumer TENS (Transcutaneous…
Medical specialties that can change the future of healthcareTelehealther - Jun 26, 2017
Many technological advancements have already managed to find their place in health clinics, and just around the corner are new…